<乌鸦传媒>Significant Improvement in Vitiligo With JAK Inhibitor Therapy Durable improvement in pigmentation with topical ruxolitinib, oral ritlecitinib Mar 29, 2022
<乌鸦传媒>Atopic Dermatitis: Promising Data for New Mechanistic Approach Rapid responses in a majority of patients in small trial of eblasakimab Mar 28, 2022
<乌鸦传媒>Targeted Antibody Provides Significant Relief From Itchy Nodular Condition Dupilumab reduces itch, lesion count in first phase III trial for prurigo nodularis Mar 28, 2022
<乌鸦传媒>Dramatic, Durable Hair Growth With Oral JAK Inhibitor Oral baricitinib superior to placebo at 36 weeks in BRAVE-AA1 and BRAVE-AA2 trials Mar 27, 2022
<乌鸦传媒>Rapid Improvement in Atopic Dermatitis With New JAK1 Inhibitor Plus: First-in-class drug shows promise in AD, BTK inhibitor active in pemphigus May 03, 2021
<乌鸦传媒>Topical JAK Inhibitor Shows Promise in Vitiligo Half of patients had 90% improvement after 2 years of treatment Apr 30, 2021
<乌鸦传媒>High Rate of Hyperhidrosis Relief With Topical Agent Benefit for 86% of patients treated with sofpironium bromide Apr 29, 2021
<乌鸦传媒>Rapid Improvement in Atopic Dermatitis With Topical JAK Inhibitor Disease activity index improved as early as week 1 with delgocitinib cream Apr 27, 2021
<乌鸦传媒>Significant Improvement in Hand Eczema With Pan-JAK Inhibitor Disease activity indicators reduced, no safety signals with gusacitinib versus placebo Apr 26, 2021
<乌鸦传媒>Drug 'TYKs' All the Boxes in Two Plaque Psoriasis Trials Significantly higher response rates with TYK2 inhibitor deucravacitinib versus apremilast Apr 25, 2021
<乌鸦传媒>Big Win in Psoriasis for Dual IL-17A/17F Inhibitor Significant differences in clearance with bimekizumab vs secukinumab at all time points Apr 23, 2021
<乌鸦传媒>Clascoterone Offers Relief in Moderate-to Severe Acne Topical androgen receptor inhibitor led to a decline in inflammatory, non-inflammatory lesions Mar 06, 2019
<乌鸦传媒>When Not to Use Biologics for Psoriasis Comorbidities, special populations, idiosyncrasies influence decisions Mar 06, 2019
<乌鸦传媒>Do Keloids Convey a Higher Cancer Risk? Taiwanese researchers show association between raised scars and cancers Mar 03, 2019
<乌鸦传媒>Injectable Enzyme Promising for Women With Cellulite Collagenase clostridium histolyticum significantly improved cellulite severity on the buttocks Mar 03, 2019
<乌鸦传媒>Topical Therapy Improves Hyperhidrosis in Kids Sweat production falls, QOL rises with anticholineregic wipes Feb 20, 2018
<乌鸦传媒>Psoriasis Falls to Novel Biologic Bimekizumab brings clear or almost clear skin to vast majority of patients in phase II trial Feb 19, 2018
<乌鸦传媒>Risankizumab Resolves Psoriasis in Half of Patients Superior to ustekinumab for many endpoints in two RCTs Feb 19, 2018
<乌鸦传媒>Gene Expression Test Impacts Melanoma Management Test assessed high-risk patients based on biological data from 31 genes in tumor tissue Feb 18, 2018
<乌鸦传媒>Using Biology of Atopic Dermatitis to Improve Therapy Following psoriasis model of molecular targeting Feb 18, 2018
<乌鸦传媒>AAD 2018: Emphasis on 'Adult' Education, Engagement More hands-on sessions, direct participant involvement Feb 16, 2018
<乌鸦传媒>Brief, Broad-Area Treatment Clears Actinic Keratosis High patient satisfaction with ingenol disoxate Mar 08, 2017
<乌鸦传媒>Transplant Patients Have More Infections After Mohs Surgery Immunosuppressed populations significantly prone to post-procedure complications Mar 08, 2017
<乌鸦传媒>RA Drug Active in Psoriatic Arthritis Multiple endpoints improved with tofacitinib Mar 07, 2017
<乌鸦传媒>Psoriasis Responds After Biologic Failure PASI-75 rate exceeds 80% with tildrakizumab Mar 06, 2017
<乌鸦传媒>Cimzia Passes Muster in Two Psoriasis Trials Met primary efficacy goals versus placebo; third trial still to come Mar 06, 2017
<乌鸦传媒>Dramatic Responses to Biologic in Atopic Dermatitis High marks for dual cytokine inhibitor in adults, children Mar 06, 2017
<乌鸦传媒>Bacterial Spray Promising for Keratosis Pilaris Topical Nitrosomonas eutropha improved skin texture in small trial Mar 06, 2017
<乌鸦传媒>One Biologic Bests Another in Head-to-Head Psoriasis Trial Taltz turns in better results than Stelara on severity indices Mar 05, 2017
<乌鸦传媒>Nitric Oxide Gel Shows Promise for Genital Warts Full clearance of baseline warts achieved in phase II trial Mar 05, 2017
<乌鸦传媒>AAD: A Skin-Based Test for Alzheimer's Disease? Small study show high Tau protein levels in buccal swabs Mar 05, 2017
<乌鸦传媒>New Science, Hot Topics Featured at AAD Meeting First-time sessions account for 25% of program Mar 02, 2017
<乌鸦传媒>Herpes Vaccine Cuts Viral Shedding Shedding down by as much as 55%, lesion count by 69% Mar 08, 2016
<乌鸦传媒>New Device for Cellulite Tx Offers Lasting Results Patients express long-term satisfaction with tissue stabilized-guided subcision Mar 08, 2016
<乌鸦传媒>Anti-IL17A Tx Clears Most Cases of Psoriasis Durable long-term responses with ixekizumab, secukinumab Mar 07, 2016
<乌鸦传媒>Positive Data for New Atopic Dermatitis Drugs Topical PDE4 inhibitor, anti-IL-31 antibody improve signs, symptoms Mar 06, 2016
<乌鸦传媒>A Tale of Two Psoriasis Numbers: PASI 75 or 90? Debate over complete clearance goals ends in draw Mar 06, 2016
<乌鸦传媒>Spironolactone: The 'Other' Hormonal Acne Therapy Expert: drug is effective and its safety issues can be managed Aug 28, 2015
<乌鸦传媒>Bed Bug Resurgence a Multifactorial Issue Hygiene, insecticide bans, globalization all contribute Aug 27, 2015
